Unveiling the Therapeutic Targets and Active Components of Xianlinggubao Capsule in Osteoarthritis and Osteoporosis through Network Pharmacology and Bioinformatics Analysis
This study has demonstrated that danshenxinkun B and miltirone may be pivotal agents in treating OA and OP by down-regulating the expressions of Ptgs2, Fos, and Tnfaip3.
Authors
- Qing Ma (ORCID: https://orcid.org/0000-0003-0123-9913)
- Xuejiao Hua
- Jianhui Liu (ORCID: https://orcid.org/0000-0001-8921-7350)
- Xuhui Ma
Institutions
- Chongqing University (CN)
- Chongqing University of Science and Technology (CN)
- Shanghai Ship and Shipping Research Institute (CN)
- Taiyuan Central Hospital (CN)
- Fourth People's Hospital of Taiyuan (CN)
- Chongqing University of Technology (CN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-10-08
- DOI
- https://doi.org/10.2174/0113816128406157250911093530
- Primary Topic
- Bone Metabolism and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00